Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma

NCT04981886 is registered in ClinicalTrials.gov with Salus University as lead sponsor.

NCT NCT04981886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04981886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma
Lead sponsor
Salus University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2021
Completion date
August 31, 2022
Enrollment
115 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal tension glaucoma